Clinical Trials Browser

Phase 1 × Glioblastoma × Immunotherapy, Adoptive × Clear all

NCT06815029 2025-06-26

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Phase 1 Recruiting

Astrocytoma, Glioblastoma, Lymphoma, Follicular

NCT02664363 2023-02-17

ExCeL

Phase 1 Terminated

3 enrolled 8 charts

Glioblastoma, Gliosarcoma